| Primary information |
|---|
| ID | antitb_1556, |
| Name | 25613372 |
| N-Terminal modification | 1-C134mer |
| C-Terminal Modification | H-Ntridec-Nlys-Nspe-Nspe-Nlys_NH2 |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | Nlys = N-(4-aminobutyl)glycine, Nssb = (S)-N-(sec-butyl)glycine |
| Nature | 5 |
| Source | L |
| Origin | Cationic |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
| Cell Line | MIC = 6.3 μg/ml |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |